September 30, 2021
A New Jersey federal judge Thursday nixed Allergan's bid to toss a generic drug price-fixing lawsuit on the grounds that funds affiliated with TIAA-CREF were too late in filing their claims since similar antitrust actions based on related government investigations were filed more than a year earlier.
January 30, 2020
Allergan shareholders on Wednesday told a New Jersey federal judge not to let the company slip their proposed securities class action accusing the company of keeping them in the dark about its purported role in antitrust schemes.
December 09, 2019
Allergan is asking a New Jersey federal court to throw out a securities suit from funds affiliated with TIAA-CREF alleging the pharmaceutical company kept investors in the dark about its purported role in antitrust schemes, saying the claims were filed too long after related government investigations were publicly revealed.
November 06, 2017
Funds affiliated with TIAA-CREF slapped Allergan PLC with a securities suit in New Jersey federal court on Friday, alleging the company's stock was artificially inflated for years because its executives concealed its involvement in a widespread generic-drug price-fixing scandal.